Date | Insider | Price | Amount |
---|---|---|---|
3-6-2024 Insider Buy |
Lantheus Alpha Therapy, LLC |
$0.95 CAGR » |
$57,409,487.05 60,431,039 shares |
1-30-2024 Insider Buy |
Robert F. Williamson III Director |
$0.71 CAGR » |
$90,710.05 127,206 shares |
1-25-2024 Insider Buy |
Robert F. Williamson III Director |
$0.49 CAGR » |
$25,478.04 51,996 shares |
1-24-2024 Insider Buy |
Markus Puhlmann Chief Medical Officer |
$0.50 CAGR » |
$139,888.00 280,000 shares |
12-21-2023 Insider Buy |
Robert F. Williamson III Director |
$0.33 CAGR » |
$1,202.56 3,663 shares |
12-19-2023 Insider Buy |
Markus Puhlmann Chief Medical Officer |
$0.32 CAGR » |
$188,737.33 595,425 shares |
12-19-2023 Insider Buy |
Robert F. Williamson III Director |
$0.29 CAGR » |
$6,977.60 23,680 shares |
12-18-2023 Insider Buy |
Jonathan Robert Hunt Chief Financial Officer |
$0.26 CAGR » |
$32,337.50 125,000 shares |
Also See: Institutional Holders of CATX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 03/07/2024 | |
End date: | 04/30/2024 | |
Start price/share: | $1.06 | |
End price/share: | $1.68 | |
Dividends collected/share: | $0.00 | |
Total return: | 58.49% | |
Annualized Gain: | 402.81% | |
Starting investment: | $10,000.00 | |
Ending investment: | $15,849.00 | |
Years: | 0.15 |
CATX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CATX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CATX
Free CATX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the CATX Insider Buying occurred are:
ALLO Insider Buying |